Press release
Navigating the Future: COVID-19 Drug Associated APIs Market Trends and Forecast Insights, 2025 Edition
COVID-19 Drug Associated APIs Market
COVID-19 Drug Associated APIs Market Size Growth Forecast: What to Expect by 2025?
The market size for APIs related to COVID-19 drugs has experienced significant growth in recent years. It is projected to expand from $6.75 billion in 2024 to $7.14 billion in 2025, with a compound annual growth rate (CAGR) of 5.8%. This growth during the historical period can be traced back to the escalating prevalence of COVID-19, heightened awareness regarding treatment alternatives for COVID-19, wider availability of COVID-19 drugs, increased demand for these drugs for preventive measures, policy initiatives by government, and supply chain robustness.
How Will the COVID-19 Drug Associated APIs Market Size Evolve and Grow by 2029?
The market size of APIs related to COVID-19 drugs is anticipated to experience substantial growth in the coming years, with an estimated worth of $9.08 billion by 2029, and a compound annual growth rate (CAGR) of 6.2%. Factors contributing to this growth during the forecast period include the creation of new COVID-19 drug treatments, an increase in clinical trials for COVID-19 medications, surging demand for COVID-19 vaccines, the emergence of variants, vaccination drives, and planning for pandemics. The forecast period is also expected to witness trends such as bespoke API production, diversification of API origins, progressive manufacturing techniques, digital and data analytics, as well as the focus on sustainability and green chemistry.
View the full report here:
https://www.thebusinessresearchcompany.com/report/covid19-drug-associated-api-global-market-report
What Drivers Are Propelling the Growth of COVID-19 Drug Associated APIs Market Forward?
The necessity for antiretrovirals, antimalarials, bronchodilators, sedatives, and other types of drugs for respiratory issues is boosting the requirement for the production of active pharmaceutical ingredients (APIs), which are used in creating COVID-19 medications. APIs are the biologically potent components used in the manufacture of pharmaceutical drugs. Remdesivir and Favipiravir are currently widely used antiviral medications in the treatment of COVID-19 patients. The US and Japan have given emergency approval to Remdesivir in treating patients with COVID-19. The FDA sanctioned the use of Airsupra (made of albuterol and budesonide) in the form of an inhalation aerosol for intervening as-required to treat or prevent bronchoconstriction, thereby reducing the risk of asthma attacks in patients who are 18 years and older. Favipiravir, a prevalent treatment for influenza in Japan, has shown effective results in COVID-19 patients as well. With COVID-19 being a respiratory disease, the use of bronchodilators has skyrocketed. This heightened need for antivirals, antimalarials and bronchodilators is thus expected to fuel the demand for APIs linked with COVID-19 drugs throughout the predicted timeline.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3248&type=smp
Which Emerging Trends Are Transforming the COVID-19 Drug Associated APIs Market in 2025?
Major players in the pharmaceutical sector, particularly those producing APIs related to COVID-19 drugs, are concentrating on strategies such as expanding capabilities or production properties to cater to the escalating demand influenced by the globally growing number of COVID-19 patients. Illustratively, in October 2023, Merck & Co., Inc., an American pharmaceutical entity, expects to venture into the deuterated raw compound market, valued approximately at $100 million, through a recent collaboration with India's Heavy Water Board. This market has the capacity to soar to $1 billion within the next half to full decade. Merck aims to bolster the chemical, pharmaceutical, and technical industries of India by supplying superior compounds, utilized in the production of drugs, semiconductors, OLEDs, and electronic components. Presently, Avigan is under clinical trial to evaluate its safety and effectiveness in treating COVID-19 affected individuals.
What Are the Key Segments in the COVID-19 Drug Associated APIs Market?
The COVID-19 drug associated apis market covered in this report is segmented -
1) By Drug Class: Antimalarials, Bronchodilators, Antibiotics, Antivirals, Other Drug Class
2) By Synthesis Type: Synthetic, Biotech
3) By Business Mode: Captive API, Merchant API
Subsegments:
1) By Antimalarials: Hydroxychloroquine, Chloroquine
2) By Bronchodilators: Beta-Agonists, Anticholinergics
3) By Antibiotics: Macrolides, Tetracyclines
4) By Antivirals: Remdesivir, Favipiravir, Lopinavir Or Ritonavir
5) By Other Drug Classes: Corticosteroids, Immunomodulators
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3248&type=smp
Who Are the Key Players Shaping the COVID-19 Drug Associated APIs Market's Competitive Landscape?
Major companies operating in the COVID-19 drug associated apis market include Dr. Reddy's Laboratories Ltd., Lianyungang Guike Pharmaceutical CO. LTD., Alembic Pharmaceuticals Ltd., Wockhardt Ltd., Sandoz Srl, Lupin Limited, Aurobindo Pharma Ltd., Shanghai Shyndec Pharmaceutical Co. Ltd., Zhejiang Yatai Pharmaceutical Co. Ltd., Zhejiang Guobang Pharmaceutical Co Ltd., Cipla Limited, Shandong Boyuan Pharmaceutical Co. Ltd., Aspiro Pharma Ltd., Qilu Antibiotics Pharmaceutical Co. Ltd., Shenzhen China Resources Jiuxin Pharmaceutical Co. Ltd., Zhejiang Cheng Yi Pharmaceutical, Star Lake Bioscience Co.Inc., Hetero Labs Ltd., Geno Pharmaceuticals Ltd., Mylan Laboratories Ltd., Ipca Laboratories Limited, Zydus Takeda Healthcare Private Limited, Mangalam Drugs & Organics, Wallace Pharmaceuticals, Zhejiang Hisun Pharmaceutical Co. Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Zhejiang Jiuzhou Pharmaceutical Co. Ltd., Zhejiang NHU Co. Ltd., Zhejiang Xianju Pharmaceutical Co. Ltd., Zhejiang Yongtai Technology Co. Ltd., Zhejiang Zhebei Pharmaceutical Co. Ltd., Zhejiang Tianyu Pharmaceutical Co. Ltd., Zhejiang Aisheng Pharmaceutical Co. Ltd., Zhejiang Aokang Pharmaceutical Co. Ltd., Zhejiang Anji Huifeng Surgical Dressings Co. Ltd.
What Geographic Markets Are Powering Growth in the COVID-19 Drug Associated APIs Market?
The countries covered in the COVID-19 drug associated APIs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3248
"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Navigating the Future: COVID-19 Drug Associated APIs Market Trends and Forecast Insights, 2025 Edition here
News-ID: 4151420 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for API
API Management Market Size, Trends Analysis 2032 by Key Vendors- Google, Cloud A …
USA, New Jersey: According to Verified Market Research analysis, the global API Management Market size was valued at USD 4.37 Billion in 2024 and is projected to reach USD 33.07 Billion by 2032, growing at a CAGR of 28.77% from 2026 to 2032.
What is the current outlook of the API Management Market and its expected growth potential?
The API Management Market is witnessing robust expansion due to the growing need…
Api 607 Vs API 608: A Comprehensive Comparison Guide Of Industrial Valve
Introduction: Why are API standards so important for industrial valves?
In high-risk industries such as oil and gas, chemicals and power, the safety and reliability of valves can directly affect the stability of production systems. The standards set by API (American Petroleum Institute) are the technical bible of industrial valves around the world. Among them, API 607 and API 608 are key specifications frequently cited by engineers and buyers.
This article will…
Vehicle API Market 2023 | Futuristic Technology- CarAPI, Caruso, One Auto API, A …
The Vehicle API market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The Vehicle API report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period.
The Vehicle API research report also provides insights of different regions that are…
Face Recognition API Market Growth, Business Overview 2023, and Forecast to 2030 …
Facial recognition is a way of recognizing a human face through technology. A facial detection system uses biometrics to map facial features from a photograph or video. It compares information with a database of known faces to find a match. Moreover, the accuracy of facial recognition systems has improved way better in the last decade. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger,…
API Management Market Report 2018: Segmentation by Solution (API Portal, API Gat …
Global API Management market research report provides company profile for Akana, Inc. (U.S.), Apiary, Inc. (U.S.), Axway, Inc. (France), CA Technologies, Inc. (U.S.), Cloud Elements, Inc. (U.S.), Dell Boomi, Inc. (U.S.), DigitalML (U.S.), Fiorano Software, Inc. (U.S.), Google, Inc. (U.S.), Hewlett-Packard Enterprises Co. (U.S.), IBM Corporation (U.S.), Mashape Inc. (U.S.) and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical…
Telecom API Market: OTT Service Providers Continue Cutting into Telecom API Prof …
The highly fragmented market of telecom API holds a staggering number of service providers and aggregators that are already offering their APIs to various telecom carriers. Alcatel Lucent, Apigee Corp., and Fortumo OU were the leading providers of telecom API from a global perspective in 2014. Telecom carriers have partnered with them and other prominent players in the past to launch APIs in the market.
According to Transparency Market Research’s latest…
